These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 10577701)

  • 1. Do acute mucosal reactions lead to consequential late reactions in patients with head and neck cancer?
    Denham JW; Peters LJ; Johansen J; Poulsen M; Lamb DS; Hindley A; O'Brien PC; Spry NA; Penniment M; Krawitz H; Williamson S; Bear J; Tripcony L
    Radiother Oncol; 1999 Aug; 52(2):157-64. PubMed ID: 10577701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial.
    Bentzen SM; Saunders MI; Dische S; Bond SJ
    Radiother Oncol; 2001 Aug; 60(2):123-35. PubMed ID: 11439207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised trial of accelerated and conventional radiotherapy for stage III and IV squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group Study.
    Poulsen MG; Denham JW; Peters LJ; Lamb DS; Spry NA; Hindley A; Krawitz H; Hamilton C; Keller J; Tripcony L; Walker Q
    Radiother Oncol; 2001 Aug; 60(2):113-22. PubMed ID: 11439206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor response, mucosal reactions and late effects after conventional and hyperfractionated radiotherapy.
    Bernier J; Thames HD; Smith CD; Horiot JC
    Radiother Oncol; 1998 May; 47(2):137-43. PubMed ID: 9683360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer. Preliminary report on acute toxicity.
    Maciejewski B; Skladowski K; Pilecki B; Taylor JM; Withers RH; Miszczyk L; Zajusz A; Suwinski R
    Radiother Oncol; 1996 Aug; 40(2):137-45. PubMed ID: 8884967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between normal tissue reactions and local tumor control in head and neck cancer patients treated by definitive radiotherapy.
    Geara FB; Peters LJ; Ang KK; Garden AS; Tucker SL; Levy LB; Brown BW
    Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):455-62. PubMed ID: 8655367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute radiation reactions in oral and pharyngeal mucosa: tolerable levels in altered fractionation schedules.
    Fowler JF; Harari PM; Leborgne F; Leborgne JH
    Radiother Oncol; 2003 Nov; 69(2):161-8. PubMed ID: 14643953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of granulocyte macrophage-colony stimulating factor (GM-CSF) on the frequency and severity of radiation mucositis in patients with head and neck carcinoma.
    Kannan V; Bapsy PP; Anantha N; Doval DC; Vaithianathan H; Banumathy G; Reddy KB; Kumaraswamy SV; Shenoy AM
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1005-10. PubMed ID: 9169806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.
    Fu KK; Clery M; Ang KK; Byhardt RW; Maor MH; Beitler JJ
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):589-97. PubMed ID: 7790243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of conventional fractionation (five fractions per week) and altered fractionation (six fractions per week) in stage I and II squamous cell carcinoma of oropharynx: An institutional study.
    Poddar J; Sharma AD; Kunikullaya SU; Neema JP
    Indian J Cancer; 2017; 54(1):6-10. PubMed ID: 29199652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomised trial of accelerated versus conventional radiotherapy in head and neck cancer.
    Jackson SM; Weir LM; Hay JH; Tsang VH; Durham JS
    Radiother Oncol; 1997 Apr; 43(1):39-46. PubMed ID: 9165135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered and conventional fractionated radiotherapy in locoregional control and survival of patients with squamous cell carcinoma of the larynx, oropharynx, and hypopharynx.
    Krstevska V; Crvenkova S
    Croat Med J; 2006 Feb; 47(1):42-52. PubMed ID: 16489696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized clinical trial on continuous 7-days-a-week postoperative radiotherapy for high-risk squamous cell head-and-neck cancer: a report on acute normal tissue reactions.
    Suwinski R; Bankowska-Wozniak M; Majewski W; Sowa A; Idasiak A; Ziolkowska E; Windorbska W; Tarnawski R; Skladowski K; Maciejewski B
    Radiother Oncol; 2005 Oct; 77(1):58-64. PubMed ID: 16157401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute reaction parameters for human oropharyngeal mucosa.
    Denham JW; Hamilton CS; Simpson SA; O'Brien MY; Ostwald PM; Kron T; Dear KB
    Radiother Oncol; 1995 May; 35(2):129-37. PubMed ID: 7569021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancer.
    Dobrowsky W; Naudé J; Widder J; Dobrowsky E; Millesi W; Pavelka R; Grasl C; Reichel M
    Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):803-6. PubMed ID: 9845100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute mucosal radiation reactions in patients with head and neck cancer. Patterns of mucosal healing on the basis of daily examinations.
    Wygoda A; Składowski K; Rutkowski T; Hutnik M; Goleń M; Pilecki B; Przeorek W; Lukaszczyk-Wideł B
    Strahlenther Onkol; 2012 Aug; 188(8):686-91. PubMed ID: 22729281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerated radiotherapy with delayed concomitant boost in locally advanced squamous cell carcinoma of the head and neck.
    MacKenzie R; Balogh J; Choo R; Franssen E
    Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):589-95. PubMed ID: 10524410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation-free weekend rescued! Continuous accelerated irradiation of 7-days per week is equal to accelerated fractionation with concomitant boost of 7 fractions in 5-days per week: report on phase 3 clinical trial in head-and-neck cancer patients.
    Skladowski K; Hutnik M; Wygoda A; Golen M; Pilecki B; Przeorek W; Rutkowski T; Lukaszczyk-Widel B; Heyda A; Suwinski R; Tarnawski R; Maciejewski B
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):741-6. PubMed ID: 22836063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The problem of radiogenic and chemotherapy-induced mucositis of the mouth and and oropharynx exemplified by accelerated radiochemotherapy with carboplatin in patients with inoperable squamous epithelial carcinomas of the head-/neck area. Heidelberg experiences].
    Dietz A; Nollert J; Maier H; Rudat V; Flentje M
    HNO; 1995 Jul; 43(7):403-13. PubMed ID: 7545657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of the head and neck (IAEA-ACC study): a randomised, multicentre trial.
    Overgaard J; Mohanti BK; Begum N; Ali R; Agarwal JP; Kuddu M; Bhasker S; Tatsuzaki H; Grau C
    Lancet Oncol; 2010 Jun; 11(6):553-60. PubMed ID: 20382075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.